Clinical Trial Update: Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating buprenorphine/naloxone for opiate-dependence treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Substance Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED